Novel methodologies to generate small RNA expression and small RNA sponges lentiviral libraries Miguel A. Moreno-Mateos, Cristina Rodriguez-Mateo, Jose.

Slides:



Advertisements
Similar presentations
Supplementary Figure 1. AB Supplementary Figure 1. L1 and Alu retrotransposition assay. A. Schematic of L1 retrotransposition plasmid (L1). ORF1 and ORF2.
Advertisements

Supplementary Figure 1. MiR-30a binding sites in NOTCH1 and NOTCH2 3’UTRs. The miR-30a binding site in NOTCH1 (nucleotides of the human 3’UTR.
MiR-19b/20a/92a regulates the self- renewal and proliferation of gastric cancer stem cells Journal of Cell Science (IF=5.325) 报告人:黄美玲
Fig. 1 Screening for miRNAs that regulate primordial follicle assembly in mouse ovaries. (a) A flow chart of the screening strategy. miRNAs that expressed.
LOGO Isolation and characterization of regulators of oxidative stress induced apoptosis in yeast Yaron Fireizen, Christine Crozier and Julie Anderson Biology.
Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.
B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.
-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.
Novel small RNAs expression libraries uncover hsa-mir30c and hsa-mir30b as key factors in anoikis resistance Miguel A. Moreno-Mateos*, Verónica Barragán*,
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of a MicroRNA/TP53 Feedback Circuitry.
Products > 293T/17 Transfection Reagent (Embryonic Kidney Cells, CRL-11268) Altogen Biosystems offers the 293T/17 Transfection Reagent among a host of.
Altogen Biosystems offers the J774A Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. The J774A Transfection Reagent.
Products > VERO Transfection Reagent (Monkey Kidney Cells) Altogen Biosystems offers the VERO Cell Transfection Reagent among a host of 100+ cell line.
Altogen Biosystems offers the 786-O Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. 786-O Transfection Reagent.
Products > MCF-7 Transfection Reagent (Breast Cancer, HTB-22) Altogen Biosystems offers the MCF-7 Transfection Reagent among a host of 100+ cell line specific.
Products > Transfection Reagent for C6 Cells (Glioma Cells, CCL-107) Altogen Biosystems offers the C6 Transfection Reagent among a host of 100+ cell line.
Products > 3T3-L1 Transfection Reagent (Embryonic Fibroblast Cells, CL-173) Altogen Biosystems offers the 3T3-L1 Transfection Reagent among a host of 100+
Figure S1 A B Figure S1. SPATA2 is required for TNFα or zVAD.fmk induced necroptosis in L929 cells. (A) L929 cells were transfected with a pool of four.
Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
Volume 342, Issue 1, Pages (January 2014)
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
AntimiR-30b Inhibits TNF-α Mediated Apoptosis and Attenuated Cartilage Degradation through Enhancing Autophagy Cell Physiol Biochem 2016;40:
Volume 16, Issue 3, Pages (March 2008)
Volume 145, Issue 2, Pages (August 2013)
MicroRNA-451 plays a role in murine embryo implantation through targeting Ankrd46, as implicated by a microarray-based analysis  Zhengyu Li, M.D., Jia.
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal–induced apoptosis by Marie-Liesse Asselin-Labat,
UHRF1 is regulated by miR-9 in colorectal cancer
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 136, Issue 2, Pages (February 2009)
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
MiR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. miR‐199a directly targets ERBB2 and ERBB3, whereas miR‐125b targets ERBB3. (A)
Volume 9, Issue 2, Pages (February 2011)
I-Cheng Ho, Martin R Hodge, John W Rooney, Laurie H Glimcher  Cell 
Volume 13, Issue 6, Pages (June 2013)
Volume 17, Issue 3, Pages (February 2005)
Volume 22, Issue 10, Pages (October 2014)
Volume 145, Issue 2, Pages (August 2013)
Volume 11, Issue 12, Pages (June 2015)
Volume 137, Issue 1, Pages (July 2009)
Volume 5, Issue 4, Pages (April 2000)
Robert Schickel, Sun-Mi Park, Andrea E. Murmann, Marcus E. Peter 
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Volume 37, Issue 1, Pages (January 2010)
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 12, Issue 3, Pages (September 2003)
Volume 50, Issue 2, Pages (April 2013)
Hongli Lin, Xiangmei Chen, Jianzhong Wang, Zhiheng Yu 
Volume 126, Issue 4, Pages (April 2004)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation  Dimitrios Iliopoulos, Heather A. Hirsch,
17β-Estradiol Inhibits Oxidative Stress-Induced Apoptosis in Keratinocytes by Promoting Bcl-2 Expression  Naoko Kanda, Shinichi Watanabe  Journal of Investigative.
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 18, Issue 9, Pages (September 2010)
Ulf Andersson Ørom, Finn Cilius Nielsen, Anders H. Lund  Molecular Cell 
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
Volume 4, Issue 4, Pages (April 2015)
Figure 4. MicroRNA (miR)-195 and miR-497 directly targets CD274
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 33, Issue 1, Pages (July 2010)
Volume 55, Issue 1, Pages (July 2014)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Targeting DCLK1 by miRNA-137.
Presentation transcript:

Novel methodologies to generate small RNA expression and small RNA sponges lentiviral libraries Miguel A. Moreno-Mateos, Cristina Rodriguez-Mateo, Jose A. Pintor-Toro Avda. Americo Vespucio s/n. Edif. CABIMER Parque Cientifico y Tecnolgico Cartuja 93 CP Sevilla (SPAIN) Telephone: Conclusion The work presented here provides a detailed description regarding the generation of libraries of small RNAs and anti-small RNAs or small RNA sponges. One the one hand, our data highlight the power of the system to generate novel small RNA expression libraries that can be used to perform large-scale screens for gain of function phenotypes in any given biological phenomenon. As a proof of principle, and as an example of the identification of novel functions for known miRNAs, we isolated two miRNAs that confer cellular resistance to anoikis. Furthermore, the unbiased nature of our technology provides the possibility to discover previously undescribed miRNAs and even other types of small RNAs with regulatory function, which constitutes an important breakthrough when compared to current approaches. On the other hand, the small RNA sponge library is based on novel and original technologies that will enable us to block any small RNA present into the cell. This new technology has notable advantages; among them, it is accessible to any laboratory with some training in molecular biology, it is relatively cheap and its execution is non-dependent of any sophisticated infrastructure. So far, there are no anti-small RNA libraries to carry out functional genetic screenings, and, therefore, they show an unexplored potential for high-throughput screenings related to many biological processes and pathologies. We believe that this methodology will help to the better understanding of the complex mechanisms underlying the control of gene expression by small non-coding RNAs. Figure 1. Mature miRNAs expressed under the control of dual convergent promoters are functionally similar to full-length expressed miRNAs. (A) Schematic drawing showing the plasmid used to express mature miRNAs and others small RNAs. (B) RNAse protection assay of miR-21, miR-19a transiently overexpressed from the pLENT-DUAL plasmid (upper and lower panel). miR-21 full-length (miR-21 FL) was expressed from a pCMV-miR-21 plasmid. Control (Ctr) cells expressed the empty vectors pLENT-DUAL or pCMV. Y corresponds to yeast RNA. (C) Transient transfections were carried out in HEK-293T cells, using pLENT-DUAL-21 (expressing the mature form of miR-21) or pCMV-miR-21 full-length, pLuc-BS carrying a binding site for miR-21, pCMV-Renilla (normalization control) at 100:10:1 proportions, respectively. Firefly and Renilla activities were measured 40 h after transfection (D) Similar luciferase assay as described in C using a plasmid harbouring a 652 nt wild-type sequence corresponding to the 3′-UTR of Pdcd4 at the 3′-position of the luciferase reporter gene. (E) Similar luciferase assay as described in C using HCT116 Dicer -/- cells infected with a lentivirus expressing a small hairpin RNA against Dgcr8 were used. All transfections were performed in triplicate, and results are shown as the averages ± standard errors of the means. The data were subjected to two-tailed student’s t test (* p< 0.05; ** p< 0.01; *** p< 0.001) 3’utr pdcd4 ** A) B) C) D) E) Novel small RNA expression libraries uncover hsa-miR-30b/c as key factors in anoikis resistance Figure 2. A functional screening using a novel small RNAs expression library reveals hsa-miR-30b and hsa-miR-30c as repressors of anoikis. (A) Scheme illustrating the small RNA cloning strategy to generate expression libraries based on the pLENT-DUAL lentiviral vector. (B) Pie chart representing the percentage of the different class of small RNAs in the library. On the right, a list of 15 high frequency miRNAs in the library. Below, a correlation between miRNAs expressed in MDA-MB-231 cells and miRNAs cloned in the library (logarithmic scale). (C) Immortalized RPE1 cells were infected with a lentiviral expression library containing a small RNAs collection from the MDA-MB-231 cell line. RPE1 infected cells were cultured for 19 days in agar dishes at low confluence avoiding any contact and surviving clones transferred to adhesive culture dishes to allow the growth of anoikis resistant cells. DNA from these clones was isolated and sequenced. (D) Table showing the small RNA sequences overexpressed in anoikis resistant clones. (E) Percentage of apoptotic RPE1 cells (SubG1) infected with lentivirus containing candidate mature miRNAs or empty vector (control). Three days after infection, cells were deprived of serum for 24 hours and then cultured in polyhema (PH) plates plus methyl cellulose (2%) in serum free medium for another 24 hours. (F) Percentage of apoptosis in RPE1 cells infected with lentivirus carrying full-length miR-30b, miR-30c-1, miR-30b/c mature miRNAs (Lent-30b/c) and the corresponding empty vectors as controls in a similar assay as described in E. The experiments were performed in triplicate and results are shown as the averages ± standard errors of the means. The data were subjected to two-tailed student’s t test (* p< 0.05; ** p< 0.01) B) Full-lengthpLENT-DUAL * * ** C) D)E) * ** Ctr 30b 30c Active CASP3 ACTB Pro-CASP3 p53 ACTB Ctr 30b 30c ACTB BIM Ctr 30b 30c *** ** A)B)C) Figure 3. Hsa-miR-30b and hsa-miR-30c downregulate CASP3 expression through its 3’ UTR for anoikis resistance. (A) Western blot analysis of p53, CASP3 and BCL2L11 (BIM), three putative target proteins of miR-30b/c related to anoikis. RPE1 cells were infected with lentivirus expressing full-length miR-30b, miR-30c-1 (miR-30c) or empty vector as control. Active CASP3 was analysed in cells cultured under anoikis conditions as described in Figure 2E.  -Actin (ACTB) was used as the loading control. (B) Schematic representation of the caspase-3 3’UTR containing two putative binding sites for miR-30b/c. The 3’UTR of caspase-3 mRNA was cloned downstream of the open reading frame of luciferase (pLuc-BS). Both broadly ( ) and poorly ( ) conserved putative miRNA regulatory elements of the caspase-3 3’UTR were mutated (Mut1 and Mut2, respectively) and cloned along with the wild type 3’UTR (WT). HEK-293T cells were transiently contransfected with plasmids overexpressing full-length miRNAs (miR-30b, miR-30c-1 or empty vector as control), pLuc-3’UTR CASP3 (WT, Mut1 or Mut2) and pCMV-Renilla at 100:10:1 proportions, respectively. Firefly and Renilla activities were measured 40 h after transfection. The luciferase activity normalized to Renilla is shown (lower panel). Transfections were performed in triplicate, and results are shown as the average ± standard errors of the means The data were subjected to two-tailed student’s t test (** p< 0.01; *** p< 0.001) (C) RPE1 cells were co-infected with both lentiviruses expressing full-length miR-30b/c and the ORF of caspase-3. Western blot analysis of pro-CASP3, active CASP3 and ACTB is shown for RPE1 cells growing either in complete-medium under adherent conditions (-PH) or in anoikis-inducing conditions (+PH). Flow citometry analysis of the levels of apoptosis in CASP3 infected cells growing under anoikis-inducing conditions (lower panel). Figure 4. Hsa-miR-30b and hsa-miR-30c reduce cell death induced by TRAIL and delay acini clearance in MCF10A cells. (A) Cells were infected with lentivirus containing full-length miR-30b, miR-30c and empty vector as control. Four days after infection, cells were cultured in the presence of Trail (500 ng/ml) for seven hours and the percentage of apoptotic cells was determined (SubG1). (B) Effects of overexpression of miR-30b/c on MCF10 acini morphogenesis assays. Cells were infected as in A and assayed for acinar clearance. For 24 days, acini were fixed and analyzed by confocal microscopy every 6 days. The experiment was performed in triplicate, and 100 acini were analyzed in each condition. Percentage of acini containing four or less intact nuclei in lumen was measured at the indicated time points during morphogenesis. Results are shown as the averages ± standard errors of the means. The data were subjected to two-tailed student’s t test (*p< 0.05; ** p< 0.01) A)B) Design and generation of small RNA sponges libraries A)B) Figure 5. Small RNA sponges library. (A) Schematic drawing of the strategy to generate a miRNA sponge library. S, sense small RNA; AS, antisense small RNA (B) Map of the pSIN-DUAL vector. Luciferase gene has been inserted and two restriction sites, NotI and XbaI, have been generated into the 3’ UTR for subcloning small RNAs sponges. Abstract MicroRNAs (miRNAs) have been widely studied in order to elucidate their biological functions. MicroRNAs libraries carrying out genetic screens by gain-of-function and lack-of-function approaches have been used to uncover their different roles. However, these strategies have shown limitations due to their high cost and/or technical difficulties. In this work, we have developed two novel methodologies to express or deplete mature miRNAs and other small RNAs. With the first methodology we have generated lentiviral-based libraries expressing small RNAs, and with the second methodology we have generated lentiviral-based libraries of anti-small (sponge) RNAs. Both libraries contain the whole small RNA population from any given cell type or tissue including known and unknown small RNAs. This opens the possibility of identifying novel small RNA-coding genes with a physiological role. Altogether, these novel methodologies provide powerful and effective ways to reveal novel small RNAs involved in a particular biological process. U6H1 uu 5’ pLENT-DUAL uu 5’ A) Small RNA isolation nt MDA-MB-231 (4175) 5’P5’P OH 3’ 5’P5’P ddC 3’ 5’OH ddC 3’ T4 RNA ligase ddC 3’ RT-PCR 5’OH OH 3’ BbvII pLENT-DUAL U6 H1 5’OHOH 3’ dephosphorylation phosphorylation 5’P5’P ddC 3’ T4 RNA ligase Cloning Independent clones selection Culture in attached conditions CCTACAGGTA Anoikis screening (19 days in agar) Sequencing surviving clones sRNA candidates F) Patent pending: P